investorscraft@gmail.com

Intrinsic Value of Centene Corporation (CNC)

Previous Close$33.31
Intrinsic Value
Upside potential
Previous Close
$33.31

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Centene Corporation operates as a diversified healthcare enterprise, primarily serving government-sponsored healthcare programs such as Medicaid, Medicare, and the Health Insurance Marketplace. The company generates revenue through managed care services, offering health insurance plans, pharmacy benefits management, and specialty services. Centene’s business model is anchored in its ability to administer cost-effective healthcare solutions for underserved populations, leveraging scale and integrated care delivery. As one of the largest Medicaid managed care organizations in the U.S., Centene holds a dominant position in this niche, complemented by strategic acquisitions that expand its geographic and service footprint. The company’s focus on value-based care and partnerships with providers enhances its competitive edge in a highly regulated and competitive sector. Centene’s diversified portfolio mitigates reliance on any single program, providing stability amid policy shifts. Its market leadership is reinforced by long-term government contracts and a growing emphasis on addressing social determinants of health, positioning it as a critical player in the evolving healthcare landscape.

Revenue Profitability And Efficiency

Centene reported revenue of $163.1 billion for FY 2024, reflecting its expansive operations in government-sponsored healthcare programs. Net income stood at $3.3 billion, with diluted EPS of $6.31, indicating robust profitability. Operating cash flow was $154 million, though capital expenditures of -$644 million suggest significant reinvestment in infrastructure and technology to support growth and operational efficiency.

Earnings Power And Capital Efficiency

The company’s earnings power is underscored by its ability to maintain profitability in a low-margin industry, driven by scale and cost management. Capital efficiency is evident in its strategic investments, such as technology upgrades and acquisitions, aimed at enhancing service delivery and expanding market share. The balance between growth spending and earnings retention highlights disciplined capital allocation.

Balance Sheet And Financial Health

Centene’s balance sheet shows $14.1 billion in cash and equivalents against total debt of $19.4 billion, indicating manageable leverage. The company’s liquidity position supports ongoing operations and strategic initiatives, while its debt levels are typical for a capital-intensive healthcare managed care provider. Financial health appears stable, with sufficient resources to meet obligations and fund growth.

Growth Trends And Dividend Policy

Centene’s growth is fueled by organic expansion in existing markets and acquisitions, particularly in Medicaid and Medicare Advantage. The company does not currently pay dividends, opting instead to reinvest cash flows into growth opportunities and debt reduction. This aligns with its focus on scaling operations and maintaining flexibility in a dynamic regulatory environment.

Valuation And Market Expectations

Centene’s valuation reflects its position as a leader in government-sponsored healthcare, with market expectations centered on sustained enrollment growth and margin stability. The stock’s performance is influenced by healthcare policy trends and the company’s ability to navigate regulatory changes while delivering consistent earnings.

Strategic Advantages And Outlook

Centene’s strategic advantages include its scale, diversified program portfolio, and expertise in managing complex healthcare systems. The outlook remains positive, supported by demographic trends favoring Medicaid expansion and the company’s ability to adapt to evolving healthcare needs. Risks include regulatory changes and competitive pressures, but Centene’s entrenched market position provides resilience.

Sources

Company filings (10-K), investor presentations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount